COST AND EFFECTIVENESS OF ATYPICAL-ATYPICAL ANTIPSYCHOTIC COMBINATIONS AND ATYPICAL-TYPICAL ANTIPSYCHOTIC COMBINATIONS IN PATIENTS OF PSYCHOTIC DISORDERS IN INSTALLATION OF EMERGENCY IN GRHASIA MENTAL HOSPITAL, YOGYAKARTA

Arya Dibyo Adisaputra; Endang Darmawan; Arum Siwinarni

doi:10.24071/jpsc.002453

COST AND EFFECTIVENESS OF ATYPICAL-ATYPICAL ANTIPSYCHOTIC COMBINATIONS AND ATYPICAL-TYPICAL ANTIPSYCHOTIC COMBINATIONS IN PATIENTS OF PSYCHOTIC DISORDERS IN INSTALLATION OF EMERGENCY IN GRHASIA MENTAL HOSPITAL, YOGYAKARTA

Arya Dibyo Adisaputra⁽¹⁾, Endang Darmawan^(2*), Arum Siwinarni⁽³⁾,

(1) Pharmacy Study Program, Mathematics and Natural Sciences Faculty, Universitas Tadulako
(2) Ahmad Dahlan University
(3) Mental Grhasia Hospital
(*) Corresponding Author

Abstract

Psychotic disorders create a burden on the government, family, and society because of decreasing patient productivity. The use of atypical-atypical and atypical-typical antipsychotic combinations is one of the most commonly used combinations for patients with psychotic disorders. The study was conducted to determine the average total cost and effectiveness of the therapy measured by the difference in PANSS-EC pre-post scores during intensive care. The study was conducted prospectively to analyse the total cost and effectiveness of the therapy using combinations of antipsychotics in psychotic disorders patients. The measured costs include the cost of nursing classes, laboratory, medical treatment, doctor's visit, and antipsychotic. The effectiveness is measured by the difference in PANSS-EC pre-post scores. As many as 32 treated patients with psychotic disorders met the inclusion criteria. The average cost of atypical-typical antipsychotic combination group (Rp1,184,043) was higher than atypical atypical antipsychotic combination group (Rp1,115,829). The effectiveness of the therapy was represented by the value of the difference between the PANSS-EC pre and post scores, which in this research yielded a mean of 7,125 for atypical-atypical antipsychotic combinations and 8,375 for atypical-typical antipsychotic combinations. In conclusion, there is a difference in the total average cost and effectiveness of the therapy. There is a difference between PANSS-EC pre and post scores during the time period from intensive room to quiet room in atypical-typical antipsychotic combinations compared with atypical-atypical antipsychotic combinations.

Keywords

Psychotic disorders; atypical-atypical antipsychotic combination; atypical-typical antipsychotic combination; cost; effectiveness; PANSS-EC

Full Text:

PDF

References

Amelia, D. R. & Anwar, Z., 2013. Relaps Pada Pasien Skizofrenia. Jurnal Ilmiah Psikologi Terapan, 1(1), 53-65.

Anonim, 2013. Riset Kesehatan Dasar. Badan Penelitian dan Pengembangan Kesehatan Kementerian Republik Indonesia tahun 2013. Jakarta.

Azani, E., Analisis Biaya Dan Outcome Terapi Penggunaan Antipsikotika Pada Pasien Rawat Inap Skizofrenia RSJD Surakarta Tahun 2017, Tesis, Program Studi S2 Ilmu Farmasi Fakultas Farmasi Universitas Setia Budi, Surakarta.

Correll CU., Rummel-Kluge C., CorvesC., Kane JM., Leucht S., 2009. Antipsychotic Combination vs Monotherapy in Schizophrenia: A Meta Analysis of RCT. Schizophr Bull, 32(2), 443–57.

Dongoran S. F., 2014. Gambaran Karakteristik Pasien Skizofrenia di Rumah Sakit Jiwa Daerah Provinsi Sumatera Utara Medan. Skripsi. Fakultas Keperawatan Universitas Sumatera Utara.

Fahrul, Mukaddas, A., & Faustine, I., 2014. 2 Prodi Farmasi, untad Lab. Farmakologi dan Farmasi Klinik, Prodi Farmasi, Untad 1. Online Jurnal of Natural Science, 3(1), 40–46.

Fujimaki K., Takahashi T., Morinobu S., 2012. Association of Typical versus Atypical Antipsychotics with Symptoms and Quality of Life in Schizophrenia. PLoS One, 7(5), e37087. DOI: 10.1371/ journal.pone.0037087

Haw C, Stubbs J., 2003. Combined Antipsychotics for ‘Difficult-to-manage’ and Forensic Patients with Schizophrenia: Reasons for Prescribing and Perceived Benefits. Psychiatr Bull, 27(12), 449–52.

Idaiani, S., Yunita, I., Tjandrarini, D. H., Indrawati, L., Darmayanti, I., Kusumawardani, N., &Mubasyiroh, R., 2019. Prevalensi Psikosis di Indonesia Berdasarkan Lie Kesehatan Dasar The Prevalence of Psychosis in Indonesia Based on Basic Health Research. Jurnal Penelitian Dan Pengembangan Pelayanan Kesehatan, 3(1), 9–16.

Ising, H. K., Lokkerbol, J., Rietdijk, J., Dragt, S., Klaassen, R. M. C., Kraan, T., … van der Gaag, M., 2017. Four-Year Cost-effectiveness of Cognitive Behavior Therapy for Preventing First-episode Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial. Schizophrenia Bulletin, 43(2), 365–374.

Kaplan H.I., Sadock B.J., Greb Jack., 2010. Sinopsis Psikiatri. Jilid Satu. Binarupa Aksara.

Karaeng, Nety Daud, et al., 2019. “Analisis Efektivitas Biaya Penggunaan Risperidone Kombinasi Dan Haloperidol Kombinasi Pada Pasien Skizofrenia Di Rsj. Dr. V. L. Ratumbuysang Provinsi Sulawesi Utara.” Majalah Farmasi Dan Farmakologi, 22(3), 69.

Khaira, N.R., A. Nugroho., A. Saputra, 2015. Drug Related Problems AntiPsikotik pada Pasien Skizofrenia Paranoid Akut di RS Jiwa X Jakarta. Farmasains, 2, 275-280.

Kurniawan, Y., &Sulistyarini, I., 2017. Komunitas Sehati (Sehat Jiwa dan Hati) Sebagai Intervensi Kesehatan Mental Berbasis Masyarakat. INSAN Jurnal Psikologi Dan Kesehatan Mental, 1(2), 112.

Perwitasari, D. A., 2008. Kajian penggunaan atypical antipsychotic dan conventional antipsdychotic pada pasien skizofrenia di rumah sakit Grhasia Yogyakarta. Prosiding. ISBN: 978-979-17547-0-5.

Prawati, N. L. A. G., 2017. Analisis Efektivitas Biaya Penggunaan Kombinasi Antipsikotik Tipikal Dibandingkan dengan Kombinasi Antipsikotik Tipikal dan Atipikal pada Pasien Skizofrenia Rawat Inap di RSJD Surakarta pada Tahun 2016. Skripsi. Universitas Setia Budi.

Purwandityo, G. A., Febrianti, Y., Sari, P. C., 2018. Pengaruh Antipsikotik terhadap Penurunan Skor The Positive and Negative Syndrome Scale-Excited Component, Jurnal Farmasi Klinik Indonesia, 7(1), 19–29.

Ranti, I., Octaviany, A. F., &Kinanti, S., 2015. Analisis Efektivitas Terapi dan Biaya antara Haloperidol Kombinasi dengan Risperidon Kombinasi pada Terapi Skizofrenia Fase Akut Analysis Therapeutic and Cost Effectiveness of Combination Therapy between Risperidone and Haloperidol on Acute Phase of Schiz. Mutiara Medika, 15(1), 57–64.

Riset Kesehatan Dasar (Riskesdas), 2013. Badan Penelitian dan Pengembangan Kesehatan Kementerian RI tahun 2013.

Rubio-Abadal, E., Usall, J., Barajas, A., Carlson, J., Iniesta, R., Huerta-Ramos, E., … Villalta, V., 2016. Relationship between Menarche and Psychosis Onset in Women with First Episode of Psychosis. Early Intervention in Psychiatry, 10(5), 419–425.

Starling, J., Feijo, I., &Franzcp, J. S., 2012. Psychotic Disorders of Early Onset. IACAPAP E-Textbook of Child and Adolescent Mental Health, 1–22.

DOI: https://doi.org/10.24071/jpsc.002453